Peritoneal Dialysis related complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Stable peritoneal dialysis patients (including those who are concurrently using hemodialysis) who have stable dialysis management in outpatients and do not have a history of hospitalization within a month, 2.Patients who have consented to participate in clinical trials from the person in writing 3.Patients who are more than 20 patients at the time of consent acquisition
Exclusion criteria
Exclusion criteria: 1.Patients who have not passed 3 months or more after peritoneal dialysis introduction 2.Patients with severe heart disease 3.During pregnancy at registration, during lactation, patients who wish to become pregnant during the trial observation period of this study 4.Patients participating in clinical research that may affect this trial at the time of acquisition of clinical trial consent 5.Other patients judged inappropriate by investigators or clinical trial doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficiency evaluation item Observation of lumen of peritoneal dialysis catheter Observation of peritoneal dialysis catheter abdominal side tip Intraperitoneal observation Safety Evaluation Items Pain during endoscope operation Intra-abdominal bleeding after bending of endoscope and bleeding into drainage Peritonitis signs Other adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety after endoscopic examination Abdominal pain Bleeding of peritoneal dialysis drainage Peritonitis signs Signs of infection in the exit area or subcutaneous tunnel Abnormality in specimen inspection Other adverse events Operability of clinical trial equipment Smoothness to insertion, operation and removal of curved guide catheter Smoothness to insertion and removal of the endoscope | — |
Countries
Japan
Contacts
Juntendo University Hospital Department of Nephrology and Hypertension